Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: The EVIDENCE study

Steven R. Schwid, John Thorpe, Mohammad Sharief, Magnhild Sandberg-Wollheim, Kottil Rammohan, Jeanette Wendt, Hillel Panitch, Douglas Goodin, David Li, Peter Chang, Gordon Francis

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint Dive into the research topics of 'Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: The EVIDENCE study'. Together they form a unique fingerprint.

Arts & Humanities

Medicine & Life Sciences